The long-term objective of the research plan is to delineate cellular and molecular mechanisms of brain damage caused by stroke and other cerebrovascular disorders and, thereby, to contribute to the development of preventive and therapeutic measures against these important diseases. Although much information has accumulated on the pathophysiology and neurochemical pathology of ischemic disorders the mechanisms causing neuronal necrosis and tissue infarction remain largely undefined. It has been shown, though, that the final brain damage does not only depend on the density and duration of the ischemia but also on systemic and local factors including changes in plasma hormones and release of local neurotransmitters/neuromodulators. The present project is based on findings showing that preischemic hyperglycemia and/or increased glucose delivery during ischemia cause exaggerated brain damage characterized by postischemic seizures, edema, and infarction. It has been generally assumed, but never clearly shown, that brain damage is exaggerated because increased glucose availability enhances the cellular lactic acidosis. The research plan seeks to provide answers to three main questions. First, what is the role played by the systemic consequences of hyperglycemia and ischemic stress, notably by the changes in plasma concentrations of catecholamines, corticosterone, insulin, and glucagon? Second, how do postischemic seizures arise and what is their importance in aggravating ischemic brain damage? Third, how is the density of damage related to the severity of extra- and intracellular acidosis and by what mechanisms does acidosis cause cell injury? Plasma glucose concentrations will be systematically varied in anesthetized rats subjected to transient ischemia of known density and duration, tissue acid-base changes estimated, changes in plasma hormones and neurochemical variables assessed, and the tissue damage following long-term recovery estimated by quantitative histopathology. In other experiments, the modulating influence of changes in plasma hormones will be explored. The hypothesis will be tested if the postischemic seizures arise because ischemic acidosis damages inhibitory, GABA-ergic cells and systems, including that gated in the substantia nigra. A second hypothesis to be tested is one predicting that acidosis leads to exaggerated brain damage by causing delocalization of protein-bound iron and enhanced production of free radicals, with an ensuing peroxidative damage to cell membranes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS007838-20
Application #
3393669
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1978-07-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
20
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Lund University
Department
Type
DUNS #
350582417
City
Lund
State
Country
Sweden
Zip Code
SE-2210
Yoshimoto, Tetsuyuki; Kanakaraj, Palanisamy; Ying Ma, Jing et al. (2002) NXY-059 maintains Akt activation and inhibits release of cytochrome C after focal cerebral ischemia. Brain Res 947:191-8
Yoshimoto, Tetsuyuki; Kristian, Tibor; Hu, Bingren et al. (2002) Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A. Brain Res 932:99-109
Janelidze, S; Hu, B R; Siesjo, P et al. (2001) Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia. Neurobiol Dis 8:147-54
Yoshimoto, T; Uchino, H; He, Q P et al. (2001) Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat. Brain Res 899:148-58
Kristian, T; Bernardi, P; Siesjo, B K (2001) Acidosis promotes the permeability transition in energized mitochondria: implications for reperfusion injury. J Neurotrauma 18:1059-74
Ouyang, Y B; He, Q P; Li, P A et al. (2000) Is neuronal injury caused by hypoglycemic coma of the necrotic or apoptotic type? Neurochem Res 25:661-7
Kristian, T; Gertsch, J; Bates, T E et al. (2000) Characteristics of the calcium-triggered mitochondrial permeability transition in nonsynaptic brain mitochondria: effect of cyclosporin A and ubiquinone O. J Neurochem 74:1999-2009
Kuroda, S; Janelidze, S; Siesjo, B K (1999) The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats. Brain Res 835:148-53
Kuroda, S; Tsuchidate, R; Smith, M L et al. (1999) Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 19:778-87
Yoshimoto, T; Siesjo, B K (1999) Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res 839:283-91

Showing the most recent 10 out of 135 publications